search
Back to results

Digital Imaging Versus Ophthalmoscopy (DIvO)

Primary Purpose

Congenital Cataract

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Neocam
Sponsored by
Cambridge University Hospitals NHS Foundation Trust
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional screening trial for Congenital Cataract

Eligibility Criteria

undefined - 72 Hours (Child)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

All newborn babies having the newborn physical examination

Exclusion Criteria:

None

Sites / Locations

    Arms of the Study

    Arm 1

    Arm Type

    Other

    Arm Label

    Babies undergoing newborn eye screening

    Arm Description

    Babies having newborn eye screening with the intervention (Digital Imaging) technique in addition to the standard ophthalmoscopic technique.

    Outcomes

    Primary Outcome Measures

    Sensitivity of the screening evaluation of the Neocam (intervention) test
    The proportion of patients correctly identified as having cataract by a positive Neocam screening test result. Where a higher value indicates better sensitivity of the screening test for presence of cataract.
    Specificity of the screening evaluation of the Neocam (intervention) test
    The proportion of patients correctly identified as not having cataract by a negative Neocam screening test result. Where a higher value indicates better specificity of the screening test for absence of cataract.
    Sensitivity of the screening evaluation of the standard test
    The proportion of patients correctly identified as having cataract by a positive standard screening test result. Where a higher value indicates better sensitivity of the screening test for presence of cataract.
    Specificity of the screening evaluation of the standard test
    The proportion of patients correctly identified as not having a cataract by a negative standard screening result. Where a higher value indicates better specificity of the screening test for absence of cataract.

    Secondary Outcome Measures

    Usability feedback
    Qualitative usability feedback and test preference using screener questionnaire.

    Full Information

    First Posted
    March 8, 2022
    Last Updated
    March 30, 2022
    Sponsor
    Cambridge University Hospitals NHS Foundation Trust
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05282147
    Brief Title
    Digital Imaging Versus Ophthalmoscopy
    Acronym
    DIvO
    Official Title
    Can the Diagnostic Accuracy of Newborn Eye Screening for Congenital Cataract be Improved With Digital Dual Light Source Imaging? The Digital Imaging vs Ophthalmoscopy (DIvO)Study.
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    March 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    June 2022 (Anticipated)
    Primary Completion Date
    September 2025 (Anticipated)
    Study Completion Date
    December 2025 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Principal Investigator
    Name of the Sponsor
    Cambridge University Hospitals NHS Foundation Trust

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Cataract (cloudiness of the lens) is the major cause of avoidable child blindness in the world and affects 1 in 3000 UK infants. Screening may fail to detect a cataract in an affected child (false-negative) or mistakenly suggest there is a cataract (false positive) triggering urgent unnecessary referral. Screening is currently undertaken using an ophthalmoscope into the eye to assess the reddish reflected light (red-reflex). This study aims to test if screening using a new hand-held digital imaging device (Neocam) is more accurate than the ophthalmoscope for newborn eye screening.
    Detailed Description
    Cataract (cloudiness of the lens) is the major cause of avoidable child blindness in the world and affects 1 in 3000 UK infants. Cataracts are present in both eyes in more than half of the babies affected. Surgery is required by 8 weeks of age to prevent permanent visual impairment at this critical time of vision and brain development. All UK babies are examined (screened) for cataract twice within the first 8 weeks of life but late diagnosis continues to be a problem, causing avoidable visual impairment in some affected children. Screening may fail to detect a cataract in an affected child (false-negative) or mistakenly suggest there is a cataract (false positive) triggering urgent unnecessary referral, parental anxiety and wasted NHS resources. Screening is currently performed by midwives and doctors shining a bright white light torch (an ophthalmoscope) into the eye to assess the reddish reflected light (red-reflex), similar to "red eye" seen in flash photos. Cataract causes a dark shadow on the red-reflex but the test can be difficult because bright light causes the pupils to constrict and the babies to forcefully shut their eyes. Assessment is particularly difficult in ethnic minority infants since eye pigmentation affects the hue and brightness of the red-reflex. This study aims to test if screening using a new hand-held digital imaging device (Neocam) is more accurate than the ophthalmoscope for newborn eye screening. Neocam painlessly images the eye's reflection firstly to infrared light and then to a brief green light flash. Its infrared light causes no pupil constriction or avoidance response and the reflection is bright and consistent regardless of the baby's ethnicity. Its brief green flash and immediate imaging allows a photo of the red-reflex to be captured before the pupil has time to constrict. To compare the accuracy of both tests, the investigators seek to enrol 140,000 newborn babies in a two year study period. All babies will have both the current ophthalmoscope screening test and additional Neocam imaging. If either test is potentially abnormal, the baby will be referred for specialist examination. A more accurate screening test could prevent life-long disability and reduce costs to the NHS and society. This study will allow a future estimation of what these savings might be and whether changing to a digital imaging screening service might be justified. The result may have an impact on eye screening world-wide to prevent childhood blindness from cataract.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Congenital Cataract

    7. Study Design

    Primary Purpose
    Screening
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    None (Open Label)
    Allocation
    N/A
    Enrollment
    140000 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    Babies undergoing newborn eye screening
    Arm Type
    Other
    Arm Description
    Babies having newborn eye screening with the intervention (Digital Imaging) technique in addition to the standard ophthalmoscopic technique.
    Intervention Type
    Device
    Intervention Name(s)
    Neocam
    Intervention Description
    Screening within 72 hours of birth will be completed using the digital imaging device Neocam which painlessly images the eye's reflection firstly to infrared light and then to a brief green light flash.
    Primary Outcome Measure Information:
    Title
    Sensitivity of the screening evaluation of the Neocam (intervention) test
    Description
    The proportion of patients correctly identified as having cataract by a positive Neocam screening test result. Where a higher value indicates better sensitivity of the screening test for presence of cataract.
    Time Frame
    2 years
    Title
    Specificity of the screening evaluation of the Neocam (intervention) test
    Description
    The proportion of patients correctly identified as not having cataract by a negative Neocam screening test result. Where a higher value indicates better specificity of the screening test for absence of cataract.
    Time Frame
    2 years
    Title
    Sensitivity of the screening evaluation of the standard test
    Description
    The proportion of patients correctly identified as having cataract by a positive standard screening test result. Where a higher value indicates better sensitivity of the screening test for presence of cataract.
    Time Frame
    2 years
    Title
    Specificity of the screening evaluation of the standard test
    Description
    The proportion of patients correctly identified as not having a cataract by a negative standard screening result. Where a higher value indicates better specificity of the screening test for absence of cataract.
    Time Frame
    2 years
    Secondary Outcome Measure Information:
    Title
    Usability feedback
    Description
    Qualitative usability feedback and test preference using screener questionnaire.
    Time Frame
    2 years

    10. Eligibility

    Sex
    All
    Maximum Age & Unit of Time
    72 Hours
    Accepts Healthy Volunteers
    Accepts Healthy Volunteers
    Eligibility Criteria
    Inclusion Criteria: All newborn babies having the newborn physical examination Exclusion Criteria: None
    Central Contact Person:
    First Name & Middle Initial & Last Name or Official Title & Degree
    Louise Allen
    Phone
    07941666981
    Email
    info@divostudy.org
    Overall Study Officials:
    First Name & Middle Initial & Last Name & Degree
    Louise Allen
    Organizational Affiliation
    Cambridge University Hospitals NHS Foundation Trust
    Official's Role
    Principal Investigator

    12. IPD Sharing Statement

    Learn more about this trial

    Digital Imaging Versus Ophthalmoscopy

    We'll reach out to this number within 24 hrs